Podcast: An Integrated Development and Commercialization Process for New Medicines
The P5 Approach with John Glasspool (Anthos Therapeutics)
John Glasspool, CEO and President of Anthos Therapeutics met with Steve Crom to discuss the challenges of giving patients access to new medicines. Payers, Professionals, Providers and Policymakers all influence patient access; hence, what is needed is an approach to development and commercialization that integrates the needs of all involved – the P5 process.
Watch here and learn more about the advantages of this approach.
